Clinical trial
Phase II Study of Chemotherapy Selection Based on Therapeutic Targets for the Treatment of Advanced Pancreatic Cancer
NCT01394120 is registered in ClinicalTrials.gov with Sofia Perea, Director Clinical Trials Unit. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of Chemotherapy Selection Based on Therapeutic Targets for the Treatment of Advanced Pancreatic Cancer
- Lead sponsor
- Sofia Perea, Director Clinical Trials Unit.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- December 31, 2013
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.